| NYC |
American Strategic Investment Co. |
New York City Advisors, LLC |
10% Owner
|
2026-01-09 |
P - A |
968 |
9.24 |
8,944.32 |
1,055,712 |
| BTAI |
BioXcel Therapeutics, Inc. |
MACK DAVID J. |
Director
|
2026-01-09 |
A - A |
17,000 |
0.00 |
0.00 |
17,000 |
| BTAI |
BioXcel Therapeutics, Inc. |
Bray June |
Director
|
2026-01-09 |
A - A |
17,000 |
0.00 |
0.00 |
17,000 |
| BTAI |
BioXcel Therapeutics, Inc. |
MILLER MICHAEL PATRICK |
Director
|
2026-01-09 |
A - A |
17,000 |
0.00 |
0.00 |
17,000 |
| BTAI |
BioXcel Therapeutics, Inc. |
Votruba Michal |
Director
|
2026-01-09 |
A - A |
17,000 |
0.00 |
0.00 |
17,000 |
| BTAI |
BioXcel Therapeutics, Inc. |
MUELLER PETER |
Director
|
2026-01-09 |
A - A |
17,000 |
0.00 |
0.00 |
17,000 |
| BTAI |
BioXcel Therapeutics, Inc. |
Patni Rajiv |
Director
|
2026-01-09 |
A - A |
17,000 |
0.00 |
0.00 |
17,000 |
| BTAI |
BioXcel Therapeutics, Inc. |
Laumas Sandeep |
Director
|
2026-01-09 |
A - A |
17,000 |
0.00 |
0.00 |
17,000 |
| ESTC |
Elastic N.V. |
Bone Jane E |
Officer
|
2026-01-09 |
S - D |
1,187 |
80.31 |
95,333.79 |
43,171 |
| NONE |
Fundrise Income Real Estate Fund, LLC |
Booth Richard Whitaker |
Other
|
2026-01-09 |
P - A |
1 |
10.04 |
6.85 |
670 |
| NONE |
Fundrise Real Estate Interval Fund, LLC |
Booth Richard Whitaker |
Other
|
2026-01-09 |
P - A |
15 |
11.81 |
172.28 |
5,127 |
| PTCT |
PTC THERAPEUTICS, INC. |
Boulding Mark Elliott |
|
2026-01-09 |
S - D |
1,521 |
77.46 |
117,816.66 |
112,105 |
| PTCT |
PTC THERAPEUTICS, INC. |
Boulding Mark Elliott |
|
2026-01-09 |
S - D |
686 |
78.71 |
53,995.06 |
111,419 |
| PTCT |
PTC THERAPEUTICS, INC. |
Boulding Mark Elliott |
|
2026-01-09 |
S - D |
107 |
79.52 |
8,508.64 |
111,312 |
| NTSK |
Netskope Inc |
Bousquet Raphael |
|
2026-01-09 |
C - A |
3,192 |
0.00 |
0.00 |
3,192 |
| NTSK |
Netskope Inc |
Bousquet Raphael |
|
2026-01-09 |
S - D |
3,192 |
16.38 |
52,290.39 |
0 |
| NTSK |
Netskope Inc |
Bousquet Raphael |
|
2026-01-09 |
C - D |
3,192 |
0.00 |
0.00 |
116,165 |
| BTAI |
BioXcel Therapeutics, Inc. |
Bray June |
Director
|
2026-01-09 |
A - A |
17,000 |
0.00 |
0.00 |
17,000 |
| BBIO |
BridgeBio Pharma, Inc. |
Kumar Neil |
Director
Officer
|
2026-01-09 |
S - D |
2,151 |
75.75 |
162,942.55 |
733,535 |
| BBIO |
BridgeBio Pharma, Inc. |
Kumar Neil |
Director
Officer
|
2026-01-09 |
S - D |
6,955 |
76.72 |
533,568.82 |
726,580 |
| BBIO |
BridgeBio Pharma, Inc. |
Kumar Neil |
Director
Officer
|
2026-01-09 |
S - D |
10,519 |
77.61 |
816,364.86 |
716,061 |
| BBIO |
BridgeBio Pharma, Inc. |
Kumar Neil |
Director
Officer
|
2026-01-09 |
S - D |
375 |
78.19 |
29,322.00 |
715,686 |
| BBIO |
BridgeBio Pharma, Inc. |
Kumar Neil |
Director
Officer
|
2026-01-09 |
S - D |
1,401 |
75.61 |
105,927.93 |
4,537,046 |
| BBIO |
BridgeBio Pharma, Inc. |
Kumar Neil |
Director
Officer
|
2026-01-09 |
S - D |
6,067 |
76.53 |
464,289.31 |
4,530,979 |
| BBIO |
BridgeBio Pharma, Inc. |
Kumar Neil |
Director
Officer
|
2026-01-09 |
S - D |
10,677 |
77.46 |
827,015.86 |
4,520,302 |